MDM2 expression in EBV-infected nasopharyngeal carcinoma cells

Han-Chung Wu1, Tung-Ying Lu, Jeng-Jie Lee

  • 1Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.

Insights

Epstein-Barr virus (EBV) enhances mdm2 gene expression in nasopharyngeal carcinoma (NPC) cells already expressing it, acting as an enhancer in NPC tumorigenesis. It does not directly regulate or initiate mdm2 expression in non-expressing cells.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Nasopharyngeal carcinoma (NPC) is a malignancy influenced by Epstein-Barr virus (EBV).
  • The MDM2 gene is a key regulator of the p53 tumor suppressor, and its expression is critical in tumorigenesis.
  • Understanding the interplay between EBV and MDM2 in NPC is crucial for elucidating cancer development.

Purpose of the Study:

  • To investigate whether Epstein-Barr virus (EBV) alters the expression of the p53-regulated MDM2 gene in nasopharyngeal carcinoma (NPC).
  • To determine the role of EBV infection in the regulation of MDM2 expression within NPC cells and tumors.

Main Methods:

  • Infection of NPC-TW01 cell line with EBV via IgA receptor-mediated endocytosis.
  • Analysis of mdm2 gene expression in EBV-infected (EBV+) and EBV-negative (EBV-) NPC cells and xenografts.
  • Reporter gene assays (pmdm2-Luc) to assess mdm2 promoter activity following cotransfection with p53 and EBV-LMP genes (LMP1, LMP2A).
  • Examination of mdm2 expression in NPC biopsy specimens.

Main Results:

  • MDM2 gene expression was observed in a subset of NPC cells and was enhanced in EBV+ cells.
  • MDM2+ cells appeared in clusters in both EBV+ and EBV- xenografts, with stronger expression in EBV+ tumors.
  • EBV-LMP1, but not EBV-LMP2A, enhanced p53-mediated upregulation of mdm2 expression, indicated by increased mdm2 promoter activity.
  • Tumor cells in NPC biopsies showed similar mdm2 expression patterns as observed in the animal models.

Conclusions:

  • EBV indirectly enhances mdm2 gene expression in NPC tumor cells that already express it.
  • EBV does not initiate or directly regulate mdm2 expression in cells that do not inherently express the gene.
  • EBV functions as an enhancer, contributing to NPC tumorigenesis through modulation of existing mdm2 expression pathways.